Personal information

No personal information available

Activities

Works (9)

Pediatric Hepatocellular Carcinoma: A Review of Predisposing Conditions, Molecular Mechanisms, and Clinical Considerations

International Journal of Molecular Sciences
2025-01-31 | Journal article
Contributors: Elizabeth P. Young; Allison F. O’Neill; Arun A. Rangaswami
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Data from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Figure S1-S14, Table S1-S2 & S4-S6 from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Figure S1-S14, Table S1-S2 & S4-S6 from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

Clinical Cancer Research
2024-02-16 | Journal article
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Table S3 from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Table S3 from Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach

2024-02-16 | Preprint
Contributors: Courtney R. Schott; Amanda L. Koehne; Leanne C. Sayles; Elizabeth P. Young; Cuyler Luck; Katherine Yu; Alex G. Lee; Marcus R. Breese; Stanley G. Leung; Hang Xu et al.
Source: check_circle
Crossref

Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma

Pediatric Blood & Cancer
2020-04 | Journal article
Contributors: Elizabeth P. Young; W. Susan Cheng; Melanie B. Bernhardt; Lisa L. Wang; Nino Rainusso; Jennifer H. Foster
Source: check_circle
Crossref